![]() ![]() If you are interested in early access to an Alkermes investigational therapy, please read the Alkermes Early Access Policy for additional details and eligibility considerations. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults. If early data from clinical trials suggest that an investigational treatment might offer benefits for patients facing serious or life-threatening conditions, Alkermes has a policy under which patients may be eligible to receive access to an investigational medicine outside of the context of a clinical trial. Victoza (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus. However, we understand that some patients may not be able to participate in a clinical trial. Participation in one of our clinical trials is the optimal way for patients to gain access to our investigational medicines prior to regulatory approval. Waltham, MA:2018.Īlkermes’ goal is to develop safe and effective medicines by conducting rigorous clinical trials and obtaining marketing approval from regulatory authorities, including the U.S. (Accessed May 7, 2019, at )Ģ Alkermes, Inc. Medication-assisted treatment for opioid addiction in opioid treatment programs. 1,2Īt Alkermes we believe that we share a responsibility with the treatment community, advocates, policy makers and payers to ensure that people have accurate information about each treatment option and access to all evidence-based medicines, across all settings of care.ġ Substance Abuse and Mental Health Services Administration. In fact, research shows that effective treatment programs for opioid or alcohol dependence provide a personalized, multimodal approach that may combine therapy, medications and other psychosocial support services. We are proud to collaborate with industry, government, healthcare providers and non-governmental organizations to advocate for patient access to treatments.įDA-approved medication-assisted treatments (MATs), medications used in combination with counseling and other behavioral therapies, may help those seeking treatment for opioid dependence or alcohol dependence. ![]() ARISTADA Care Support can be reached by calling 1-866-ARISTADA (1-86) or visiting.Vivitrol2getherSM can be reached by calling 1-800-VIVITROL(1-80) or visiting.If you or someone you know needs help accessing an Alkermes medicine, please contact our Patient Access Services team: We also offer programs, such as our Patient Assistance Program and our Co-Pay Savings Program, to provide support to eligible patients who are prescribed our medicines. For questions regarding your eligibility or benefits or if you wish to discontinue your participation, call 1-85 (8 8 ET. We believe we have a responsibility to support patient access to our medicines and strive to price them in a responsible manner that facilitates broad access. No matter where your patients are in their treatment journey, ARISTADA Care Support is there to help. Patient: Eligible commercially insured patients may receive their first prescription of Horizant 600 mg or 300 mg for as little as 0 (up to 60 tablets per month). The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease.Ĭall for most recent medications as the list is subject to change.At Alkermes, we apply our scientific expertise to develop medicines that are designed to help address unmet medical needs of patients affected by serious mental illness, addiction and cancer. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. HealthWell Foundation Copay Program Enrollment: Contact programįDA Approved Diagnosis - See Program Website for Details HealthWell Foundation Copay Program This is a copay assistance program Must be a US resident and treated by a US licensed healthcare providerĬomplete section, sign, attach required documentsĬo-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients. ARISTADA injection for suspension extended-release (aripiprazole lauroxil).Aristada Care Support This program provides brand name medications at no or low costĪristada Care Support Patient Assistance Program Enrollment Form ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |